Some of them say that a global threat for the development of the sector is the system of Patents: in some countries there have been published clear rules about patentability of human genes, requiring from the patent a specific description, essential and useful credibility for the gene. In the other hand, some judicial cases that decided against the offenders who made changes in the invention patents, gives some judicial support to patents systems whenever it has a rational use.
Also, there are socioeconomics and legislatives barriers which affect in the development of the area.
The Medicine History has changed after the human genome secuenciation. The principal paradigm will consist in the concept of illness, which will be classified in the abnormal genetic expression that would be produced in the cell or affected cells.
In the cancer treatment there has been important progress in this sense.
They foresee that first illnesses which will be benefit of genomita are cancer, metabolic diseases, and others from Central Nervous System (especially Parkinson and Alzheimer)
In Paraguay we can see the implementation of therapies based on biotechnology’s products, so it revolutionizes diseases like cancer, hepatitis and others. The principal handicap for using this method in our country is the high cost of the treatment. |
